During the past decade, Lynchburg General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynchburg General Hospital" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Anesiva, Inc." with 1 trials sponsored, "AtriCure, Inc." with 1 trials sponsored and "Baim Institute for Clinical Research" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynchburg General Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Lynchburg General Hospital" are "Coronary Artery Disease" (4 trials), "Acute Myocardial Infarction" (1 trials), "Cardiac Arrhythmia" (1 trials), "Cardiovascular Diseases" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "Lynchburg General Hospital" in a lesser frequency.

Most popular intervention types in "Lynchburg General Hospital" are "Device" (5 trials), "Drug" (4 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "AtriClip" (1 trials), "CGT003 (E2F Duplex Decoy)" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials) and "NBS10" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynchburg General Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Lynchburg General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Lynchburg General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lynchburg General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Lynchburg General Hospital has several departments that took part in Clinical trials: "Centra Lynchburg Hematology-Oncology Clinic Inc" - 108 trials, "Stroobants Cardiovascular Center" - 13 trials